Clinical Trials Browser

Phase 2/3 × Etoposide × CNS × Clear all

NCT06105619 2026-01-20

A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN).

Phase 2/3 Active not recruiting

Glioblastoma

NCT00539500 2019-07-26

Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma

Phase 2/3 Terminated

3 enrolled 4 charts

Neuroblastoma

NCT00749723 2018-07-20

HIT-REZ-2005

Phase 2/3 Completed

Brain Neoplasms, Ependymoma, Medulloblastoma, Recurrence